Khan M - Search Results

1

EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells.

Miyanaga A, Matsumoto M, Beck JA, Horikawa I, Oike T, Okayama H, Tanaka H, Burkett SS, Robles AI, Khan M, Lissa D, Seike M, Gemma A, Mano H, Harris CC. Miyanaga A, et al. Among authors: khan m. BMC Cancer. 2021 Mar 24;21(1):310. doi: 10.1186/s12885-021-07905-6. BMC Cancer. 2021. PMID: 33761896 Free PMC article.

2

FHIT mutations in human primary gastric cancer.

Gemma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nagashima M, Bennett WP, Harris CC. Gemma A, et al. Among authors: khan ma. Cancer Res. 1997 Apr 15;57(8):1435-7. Cancer Res. 1997. PMID: 9108441

3

Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.

Vincent F, Nagashima M, Takenoshita S, Khan MA, Gemma A, Hagiwara K, Bennett WP. Vincent F, et al. Among authors: khan ma. Oncogene. 1997 Jul 3;15(1):117-22. doi: 10.1038/sj.onc.1201166. Oncogene. 1997. PMID: 9233784

4

Differential effects of p53 mutants on the growth of human bronchial epithelial cells.

Coursen JD, Bennett WP, Khan MA, Forrester K, Pietenpol JA, Harris CC. Coursen JD, et al. Among authors: khan ma. Mol Carcinog. 1997 Jul;19(3):191-203. Mol Carcinog. 1997. PMID: 9254886

5

Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.

Burke L, Khan MA, Freedman AN, Gemma A, Rusin M, Guinee DG, Bennett WP, Caporaso NE, Fleming MV, Travis WD, Colby TV, Trastek V, Pairolero PC, Tazelaar HD, Midthun DE, Liotta LA, Harris CC. Burke L, et al. Among authors: khan ma. Cancer Res. 1998 Jun 15;58(12):2533-6. Cancer Res. 1998. PMID: 9635574

6

Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.

Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Khan MA, Jones RT, Harris CC. Ambs S, et al. Among authors: khan ma. Br J Cancer. 1998 Jul;78(2):233-9. doi: 10.1038/bjc.1998.470. Br J Cancer. 1998. PMID: 9683299 Free PMC article.

7

p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.

Przygodzki RM, Bennett WP, Guinee DG Jr, Khan MA, Freedman A, Shields PG, Travis WD, Jett JR, Tazelaar H, Pairolero P, Trastek V, Liotta LA, Harris CC, Caporaso NE. Przygodzki RM, et al. Among authors: khan ma. Pharmacogenetics. 1998 Dec;8(6):503-11. doi: 10.1097/00008571-199812000-00007. Pharmacogenetics. 1998. PMID: 9918134

8

GADD45 induction of a G2/M cell cycle checkpoint.

Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace AJ Jr, Harris CC. Wang XW, et al. Among authors: khan ma. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3706-11. doi: 10.1073/pnas.96.7.3706. Proc Natl Acad Sci U S A. 1999. PMID: 10097101 Free PMC article.

9

Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.

Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC. Bennett WP, et al. Among authors: khan ma. J Pathol. 1999 Jan;187(1):8-18. doi: 10.1002/(SICI)1096-9896(199901)187:1<8::AID-PATH232>3.0.CO;2-Y. J Pathol. 1999. PMID: 10341702 Review.

10

Mutational analysis of p73 and p53 in human cancer cell lines.

Yoshikawa H, Nagashima M, Khan MA, McMenamin MG, Hagiwara K, Harris CC. Yoshikawa H, et al. Among authors: khan ma. Oncogene. 1999 Jun 3;18(22):3415-21. doi: 10.1038/sj.onc.1202677. Oncogene. 1999. PMID: 10362363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,170 results

Search Page

Filters